Newsroom
Read the latest news from Texas A&M University.
Hagler Institute names 10 Fellows and one Distinguished Lecturer to 2026-27 class
Oct. 7, 2026 • 5 min. readThe new cohort, with expertise in climate change, quantum technology, health and more, will collaborate with Texas A&M faculty and students.
Why muscle health should be a bigger part of clinical nutrition
Oct. 7, 2026 • 4 min. readExperts call for greater attention to muscle health across aging, illness and weight loss.
Research identifies the cognitive skills that are strong indicators of math ability, providing a possible blueprint for better instruction techniques.
Genetic time capsule helps researchers rewrite the bat family tree and trace the origins of flight, echolocation
Oct. 6, 2026 • 6 min. readBy combining genomes from every living bat family with fossil evidence, researchers found that bats — and powered flight — likely originated in Europe and that echolocation emerged before modern bats began to diversify.
In one of Texas A&M University’s oldest traditions, recently deceased Aggies will be honored in a solemn ceremony.
How electrons and ions move through metal-organic frameworks offers insights to advance neuron-inspired computing.
Texas A&M, Buc-ee’s collaboration continues with new merchandise release
Oct. 1, 2026 • 3 min. readThe second co-branded T-shirt deepens the relationship between the iconic chain of travel centers and its founder’s alma mater, with more merchandise planned as Texas A&M celebrates its 150th anniversary.
New existential psychology research suggests that our true self may have less to do with some hidden identity and more to do with how easy and natural our experiences feel.
Research collaboration helps Gulf Coast communities plan for the unpredictable
Sep. 30, 2026 • 4 min. readProjects across the state use storm-surge, population and transportation data to develop real-time strategies for hurricane evacuations.
Researchers advance promising therapy for fatty liver disease
Sep. 29, 2026 • 4 min. readExperimental compound targets key disease pathways in MASH, reducing fat, inflammation and scarring in preclinical models — with hopes for future patient trials.